Shining a Light on Lipid Nanoparticle Characterization: Using an orthogonal approach to lipid nanoparticle analysis can increase the odds of project success.
| Publicado en: | BioPharm International pp. 22 - 26 |
|---|---|
| Autores principales: | , |
| Formato: | pictorial tables/charts Journal Article |
| Publicado: |
MJH Life Sciences
2022 Special Issue
|
| Acceso en línea: | Ver este registro en EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=159278356&site=ehost-live header: @attributes: shortDbName: ccm uiTerm: 159278356 longDbName: CINAHL Complete uiTag: AN controlInfo: bkinfo: dissinfo: jinfo: jid: 1542166X 5NE jtl: BioPharm International issn: 1542166X maglogo: N pubinfo: dt: 2022 Special Issue pid: 54670 pub: MJH Life Sciences place: Cranbury, New Jersey artinfo: ui: 159278356 159278356 159278356 159278356 ppf: 22 ppct: 4 formats: fmt: @attributes: type: P tig: atl: Shining a Light on Lipid Nanoparticle Characterization: Using an orthogonal approach to lipid nanoparticle analysis can increase the odds of project success. aug: au: Jones, Hanna Jankevics Markova, Natalia affil: Pharmaceutical segment marketing managers at Malvern Panalytical sug: subj: Lipids Nanoparticles RNA, Messenger Drug Development COVID-19 Vaccines Drug Efficacy Pharmaceutical Companies Sterols Drug Design pubtype: Trade Publication doctype: pictorial tables/charts Journal Article ougenre: Article ab: language: English refInfo: holdings: @attributes: islocal: N |
|---|